Scleroderma, Localized Clinical Trials
3 recruiting trials for Scleroderma, Localized. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Scleroderma, Localized clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hacettepe University (2), University of Texas Southwestern Medical Center (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Cognitive Exercise Therapy Approach (other, 1 trial), followed by Control group, Questionnaire application for child and adult scleroderma patients.
Track Scleroderma, Localized trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed...
This study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with scleroderma.
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and...
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Scleroderma, Localized, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Scleroderma, Localized, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Scleroderma, Localized, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.